Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' EQUITY (DEFICIENCY) (Details Narrative 1)

v3.19.1
STOCKHOLDERS' EQUITY (DEFICIENCY) (Details Narrative 1) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 7 Months Ended 12 Months Ended
Jun. 13, 2018
Mar. 25, 2015
May 31, 2014
Feb. 28, 2014
Nov. 30, 2014
Nov. 30, 2011
Nov. 30, 2004
Sep. 30, 2017
Dec. 31, 2018
Dec. 31, 2017
Nov. 02, 2017
Feb. 28, 2017
Jan. 31, 2017
Feb. 28, 2015
Dec. 31, 2014
Class of Stock [Line Items]                              
Number of warrant issued (in shares)                 918,366         840,000 563,910
Exercise price of warrants (in dollars per share)                             $ 2.66
Proceeds from Issuance or Sale of Equity                   $ 1,380          
Common Stock, Capital Shares Reserved for Future Issuance (in shares)             400,000                
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period         10 years   10 years                
Share-based Compensation Arrangement by Share-based Payment Award, Options                 275,038            
Share-based compensation expense recognized                 $ 889 $ 800          
Number of warrant expired (in shares)                       840,000      
Common stock, outstanding                 3,801,522 3,935,865          
Weighted average exercise price, non-vested options granted                 $ 228            
Weighted average remaining contractual life                 2 years            
Employees And Directors [Member]                              
Class of Stock [Line Items]                              
Weighted average exercise price, Exercised                 $ 2.17 $ 0.00          
New Stock Option Plan [Member]                              
Class of Stock [Line Items]                              
Common Stock, Capital Shares Reserved for Future Issuance (in shares)       714,286                      
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period       10 years                      
Number of shares available for grant (in shares)                   292,737          
NanoVibronix 2014 Long-Term Incentive Plan [Member]                              
Class of Stock [Line Items]                              
Number of shares issued (in shares) 750,000                            
Common stock, outstanding 1,464,286                            
Employees And Directors [Member] | Employee Stock Option [Member]                              
Class of Stock [Line Items]                              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Granted in Period, Fair Value                 $ 2.17 $ 0.00          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value                 $ 0 $ 22          
Exercise Price Two [Member]                              
Class of Stock [Line Items]                              
Number of warrant issued (in shares)                           420,000  
Exercise price of warrants (in dollars per share)                           $ 6.00  
Exercise Price One [Member]                              
Class of Stock [Line Items]                              
Number of warrant issued (in shares)                           420,000  
Exercise price of warrants (in dollars per share)                           $ 3.00  
Series B-2 Preferred Stock [Member]                              
Class of Stock [Line Items]                              
Reverse stock split           Seven to One                  
Number of warrants issued to purchase of common stock (in shares)           2,319,062                  
Warrants Expiration Term           Nov. 15, 2018                  
Exercise price (in dollars per share)           $ 0.199                  
Warrant [Member]                              
Class of Stock [Line Items]                              
Number of shares issued (in shares)     331,293                        
Exercise price of warrants (in dollars per share)     $ 1.393                        
Warrant Amendment [Member]                              
Class of Stock [Line Items]                              
Number of warrant issued (in shares)                         840,000    
Warrants Expiration Term                         2 years    
Number of warrant cashless exercised (in shares)                     153,333        
B2 Warrant [Member]                              
Class of Stock [Line Items]                              
Number of warrant exercised (in shares)                 68,799 85,400          
Number of warrant expired (in shares)                 177,094            
Underwriters [Member]                              
Class of Stock [Line Items]                              
Number of shares issued (in shares)                   61,224          
Number of warrant issued (in shares)                 45,918            
Exercise price of warrants (in dollars per share)                 $ 6.125            
Consultant [Member]                              
Class of Stock [Line Items]                              
Number of warrant issued (in shares)   61,000                          
Exercise price of warrants (in dollars per share)   $ 2.57                          
Warrants Expiration Term   Mar. 25, 2020                          
Accredited Investors [Member]                              
Class of Stock [Line Items]                              
Number of shares issued (in shares)               1,380              
Number of warrant issued (in shares)               552,000              
Exercise price of warrants (in dollars per share)               $ 5.90              
2017 Notes [Member]                              
Class of Stock [Line Items]                              
Number of warrant issued (in shares)                   271,096          
Exercise price of warrants (in dollars per share)                   $ 6.90          
Conversion of stock issued (in shares)                   361,462          
Warrants Expiration Term                   Nov. 01, 2022